Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
– Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, today announced that its mDNA® technology project team have been shortlisted for the “Best Technological ...
read more
Friday, November 04, 2022
Exelixis, Inc. and Catalent, Inc. announced a new license agreement under which Catalent’s Redwood Bioscience subsidiary will grant Exelixis an exclusive license to three target programs with lead antibody and/or ADC candidates.
read more
Exonbio has launched the SARS-CoV-2 Spike recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic.
read more
Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Thursday, January 22, 2015
FEops, a pioneer in the field of patient-specific 3D simulations for cardiovascular interventions, is pleased to announce the closing of a €1.3 million series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used to ...
read more
Thursday, December 02, 2021
FHI Clinical Inc. announced its intent to acquire Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South African-based CRO and a subsidiary of EOH, one of the largest technology services companies in Africa. With this ...
read more
Thursday, September 30, 2021
Curavit Clinical Research, a virtual contract research organization (VCRO) that designs and executes decentralized clinical trials (DCTs), announced today that it has joined the Decentralized Trials & Research Alliance (DTRA) to further the ...
read more
Wednesday, November 02, 2022
First Wave BioPharma, Inc. announced that it has entered into an agreement with Rho, a full-service contract research organization (CRO), for its planned Phase 2 clinical trial of an enhanced enteric microgranule delivery formulation for adrulipase.
read more
In a year when the Food and Drug Administration (FDA) has made highly publicized moves to emphasize driving data in sleep dosage recommendations and labeling issues, Cognitive Research Corporation (CRC, www.cogres.com) offers pharmaceutical companies...
read more
Formedix, a leading provider of clinical trial software solutions, has collaborated with CDISC, the global clinical research data standards development organization, to create a novel portal providing free access to ready-to-use, CDASH-compliant, ...
read more
Formedix has announced the expansion of its development and test teams.
read more
Implementing the optimum strategy for patient randomization and drug management though the use of interactive response technology can greatly reduce waste and improve efficiency in blinded clinical trials. However, IRT can increase the risks of ...
read more
Frontage Laboratories announces two senior appointments to lead its clinical services efforts. George Laskaris has been named Senior Director, Frontage Biometrics Services, bringing more than 20 years of programming, statistical and data management ...
read more
Thursday, January 23, 2020
Genome & Company has entered into a clinical trial collaboration and supply agreement with Merck KGaA and Pfizer to evaluate GEN-001 therapy in combination with avelumab.
read more